Jack F. Kramarczyk

Deutsche Telekom (United Kingdom)

Papers

2

Total Citations

338

H-Index

2

About

Jack F. Kramarczyk is a leading figure in biopharmaceutical process development, with a primary focus on advancing high-throughput screening (HTS) methodologies for chromatographic separations. His work addresses the critical challenge of accelerating the development of purification processes for protein therapeutics, which traditionally require extensive experimental time and parameter exploration. Kramarczyk’s major contributions are encapsulated in a series of influential papers, including his landmark 2008 study on HTS method development and column modeling, which has garnered 212 citations. This work established a systematic framework for rapidly evaluating chromatographic conditions, drastically reducing development timelines. He further advanced the field with his 2008 paper on ion-exchange chromatography, cited 126 times, which provided a robust, high-throughput approach for resin screening and optimization of pH and counterion concentration—key variables for achieving high capacity and selectivity in protein purification. By integrating HTS with mechanistic modeling, Kramarczyk has enabled more efficient, data-driven process design, directly impacting the speed and cost-effectiveness of biopharmaceutical manufacturing. His research remains essential reading for scientists and engineers working to streamline purification workflows for complex biologics.

Research Focus

Key Achievements

2
H-Index
2
Papers
338
Total Citations
169
Avg Citations/Paper
🏆 Most Cited Paper
High‐throughput screening of chromatographic separations: I. Method development and column modeling
212 citations · 2008
📈 Most Prolific Year: 2008 (2 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Deutsche Telekom (United Kingdom)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago